Evidence map›Paper›PMID 41471372›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

The Therapeutic Effect of a Biodegradable Long-Acting Intravitreal Implant Containing CGK012 on Neovascular Age-Related Macular Degeneration by Promoting β-Catenin Degradation.

Seoyoung Park, Jihyun Won, Jong Beom Heo, Juhyung Kang, Ye Woon Oh, Geunji Park, Giseong Lee, Jee-Hyun Lee, Gyu-Yong Song, Wonku Kang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Seoyoung ParkInspharmtech, Inc., Chuncheon 24341, Republic of Korea.ORCID 0000-0001-7340-2594
Jihyun WonInspharmtech, Inc., Chuncheon 24341, Republic of Korea.ORCID 0000-0003-1296-2285
Jong Beom HeoCollege of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.ORCID 0000-0003-0827-6960
Juhyung KangInspharmtech, Inc., Chuncheon 24341, Republic of Korea.ORCID 0000-0003-1847-5314
Ye Woon OhDepartment of Bio and Fermentation Convergence Technology, Kookmin University, Seoul 02707, Republic of Korea.
Geunji ParkDepartment of Bio and Fermentation Convergence Technology, Kookmin University, Seoul 02707, Republic of Korea.
Giseong LeeCollege of General Education, Kookmin University, Seoul 02707, Republic of Korea.ORCID 0000-0001-7480-4173
Jee-Hyun LeeAREZ Co., Ltd., Daejeon 34036, Republic of Korea.
Gyu-Yong SongCollege of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.ORCID 0000-0001-6058-5790
Wonku KangInspharmtech, Inc., Chuncheon 24341, Republic of Korea.
Sangtaek OhInspharmtech, Inc., Chuncheon 24341, Republic of Korea.

Funding

Ministry of Science and ICT, Ministry of Trade, IndKorea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfareustry, and Energy, and Ministry of Health and Welfare RS-2023-00259081
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

angiogenic/inflammatory factorsCGK012intravitreal implantneovascular age-related macular degenerationWnt/β-catenin pathway

Identifiers

PMID41471372
PMCPMC12736000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.